Journal article
Unresponsive Intractable Chronic Headache With Sitagliptin
Curēus (Palo Alto, CA), Vol.10(4), e2537
04/25/2018
DOI: 10.7759/cureus.2537
PMID: 29946505
Abstract
Sitagliptin is an anti-diabetic medication within the dipeptidyl peptidase 4 (DPP4) inhibitor class used as a single agent or in combination therapy. It is a well-studied and well-tolerated medication with commonly reported adverse events of upper respiratory tract infections, nasopharyngitis, headache, and gastrointestinal (GI) upset. Post-marketing reports have also identified associations with acute pancreatitis and joint pain. Here, we report a case of type II diabetes with chronic headache which resolved rapidly after discontinuation of sitagliptin. Our case demonstrates the need for continuous monitoring and post-marketing surveillance for drugs with tolerable side effect profile. Also, increasing patient and physician awareness of long-term side effects of these commonly used medications is essential for adequate patient safety and quality care.
Details
- Title: Subtitle
- Unresponsive Intractable Chronic Headache With Sitagliptin
- Creators
- Ahmed Zaghloul - UConn HealthCorina Iorgoveanu - UConn HealthAndrew Polio - UConn HealthAakash Desai - UConn Health
- Resource Type
- Journal article
- Publication Details
- Curēus (Palo Alto, CA), Vol.10(4), e2537
- DOI
- 10.7759/cureus.2537
- PMID
- 29946505
- NLM abbreviation
- Cureus
- ISSN
- 2168-8184
- eISSN
- 2168-8184
- Publisher
- Cureus
- Language
- English
- Date published
- 04/25/2018
- Academic Unit
- Obstetrics and Gynecology
- Record Identifier
- 9985240885402771
Metrics
2 Record Views